Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 843-855

  Whitlock, Gary ^a   MacMahon, Stephen ^a   Anderson, Craig ^a   Neal, Bruce ^a   Rodgers, Anthony ^a   Chalmers, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INDAPAMIDE; PERINDOPRIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN PROTECTION; BRAIN SCINTISCANNING; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ISCHEMIC ATTACK;

EID: 0030838821     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083190     Document Type: Conference Paper

References (37)

1. Forette F, Boller F. Hypertension and the risk of dementia in the elderly. American Journal of Medicine 1991;90(Supplement 3A):14-9.
2. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med 1996;335(5):330-6.
3. Herbert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240-257.
4. Wolfe N, Babikian V, Linn R, Knoefel J, D'Estosposito M, Albert M. Are multiple cerebral infarcts synergistic? Archives of Neurology 1994;51:211-215.
5. Benson F, Cummings J, Tsai S. Angular gyrus syndrome simulating Alzheimer's disease. Archives of Neurology 1982;39:616-620.
6. Wallin A, Blennow K, Uhlemann C, Langstrom J, Gottfries C. White matter low attenuation on CT in Alzheimer's disease and vascular dementia - diagnostic and pathogenetic aspects. Acta Neurol Scan 1989;80:518-523.
7. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5.
8. Martyn C. Blood pressure and dementia. Lancet 1996;347:1130-1.
9. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996;312:805-8.
10. Boller F, Vrtunski PB, Mack JL, Kim Y. Neuropsychological correlates of hypertension. Arch Neurol 1977;34:701-5.
11. Elias MF, Robbins MA, Schultz NR, Streeten DHP, Elias PK. Clinical significance of cognitive performance by hypertensive patients. Hypertension 1987;9(2):192-7.
12. Mazzucchi A, Mutti A, Poletti A, Ravanetti C, Novarini A, Parma M. Neuropsychological deficits in arterial hypertension. Acta Neurol Scand 1986;73:619-2.
13. Francheschi M, Tancredi O, Smirne S, Mercinelli A, Canal N. Cognitive processes in hypertension. Hypertension 1982;4:226-9.
14. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance: The Framingham Study. Am J Epid 1987;126(6):1103-14.
15. Scherr PA. Relation of blood pressure to cognitive function in the elderly. Am J Epid 1991;134(11):1303-15.
16. Elias MF, Wolf PA, Agostino RBD, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epid 1993;138(6):353-64.
17. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science 1971;172:959-62.
18. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-9.
19. Miller RE, Shapiro AP, King HE, Ginchereau EH, Hosutt JA. Effect of antihypertensive treatment on the behavioural consequences of elevated blood pressure. Hypertension 1984;6:202-8.
20. Starr JM, Whalley LJ. Senile hypertension and cognitive impairment: an overview. Journal of Hypertension 1992;10 (supplement 2):S31-S42.
21. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis C, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996;27(8):1274-82.
22. Johansson BB. Pathogenesis of vascular dementia: the possible role of hypertension. Dementia 1994;5:174-6.
23. Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 1991;48:417-20.
24. van Swieten JC, Geyskes GG, Derix MMA, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Annals of Neurology 1991;30(6):825-30.
25. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke: The Framingham Study. JAMA 1970;214(2):301-10.
26. Kannel WB, Dawber TR, Sorlie P, Wolf PA. Components of blood pressure and risk of atherothrombotic brain infarction: The Framingham Study. Stroke 1976;4:327-31.
27. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645-8.
28. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265(24):3255-64.
29. Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, Ramirez E. Treatment of hypertension in the elderly: II. Cognitive and behavioral function: Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990;15(4):361-9.
30. Prince M, Bird AS, Blizard RA, Mann AH. Is cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996;312(734):801-5.
31. PROGRESS Management Committee. Blood pressure lowering for secondary prevention of stroke: rationale and design for PROGRESS. J Hypertens 1996;14(Supplement 2):S41-S46.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method of grading the cognitive state of patients for the clinician. J Psychiatric Res 1975;12:189-98.
33. Henderson AS, Easteal S, Jorm AF, MacKinnon AJ, Korten AE, Christiansen H, et al. Apolipoprotein E allele e4, dementia, and cognitive impairment in a population sample. Lancet 1995;346:1387-90.
34. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the mini-mental state. Arch Neurol 1992;49:87-92.
35. Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol 1990;47(49-52).
36. Tombaugh TN, McIntyre NJ. The Mini-Mental State examination: a comprehensive review. J Am Ger Soc 1992;40:922-35.
37. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. (4th ed. ed.) Washington, DC: American Psychiatric Association, 1994.